Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 41-50 of 239

Page
per page
  1. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  2. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  3. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  4. BGJ398
    A3014 BGJ398
     1 Citation
    Target: FGFR
    Summary: FGFR inhibitor ,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥7 mg/mL
  5. AZD4547
    A8350 AZD4547
    Target: FGFR
    Summary: FGFR inhibitor
      ≥23.2 mg/mL
  6. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  7. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL
  8. PD 0332991 (Palbociclib) HCl
    A8316 PD 0332991 (Palbociclib) HCl
     5 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥14.48 mg/mL
  9. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  10. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor

Items 41-50 of 239

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 238item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 1 item
  3. PI3K 12item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 6item
  8. FLT3 8item
  9. GSK-3 7item
  10. PLK 4item
  11. Chk 5item
  12. Eph Receptors 3item
  13. VEGFR 19item
  14. PDGFR 14item
  15. c-Kit 6item
  16. RET 3item
  17. IRAK 2item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 6item
  20. PKB 1 item
  21. JNK 2item
  22. SGK 2item
  23. Bcr-Abl 10item
  24. MEK 4item
  25. FGFR 6item
  26. Pim 4item
  27. Ribosomal s6 kinases (RSK) 1 item
  28. MET 5item
  29. Src 8item
  30. Trk Receptors 2item
  31. EGFR 10item
  32. ROCK 6item
  33. BTK 1 item
  34. PAK 3item
  35. FAK 4item
  36. BMP and Other Activin Receptors 2item
  37. JAK 8item
  38. Syk 5item
  39. DNA-PK 3item
  40. AMPK 2item
  41. PDHK 1 item
  42. ErbB 2item
  43. S6 kinases 1 item
  44. Adenosine Kinases 2item
  45. ERK 2item
  46. c-MET 5item
  47. PKC 5item
  48. Ubiquitin-specific proteases 1 item
  49. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  50. Lyn 1 item
  51. HER2 2item
  52. Pyk2 3item
  53. LRRK2 3item
  54. Insulin and Insulin-like Receptors 2item
  55. ALK 3item
  56. ROS1 1 item
  57. Sphingosine kinases (SphKs) 1 item
  58. PKG 1 item
  59. PKA 1 item
  60. Myosin light chain kinases (MLCKs) 2item
  61. CaM-KK 1 item
  62. MELK 1 item
  63. Insulin-like growth factors (IGFs) 1 item
  64. Clk 1 item
  65. NUAK1 1 item
  66. NUAK2 1 item
  67. MK2 2item
  68. Tie-2 2item
  69. RSK 1 item
  70. ATM/ATR 3item
  71. CK1 1 item
  72. Farnesyl Diphosphate Synthases 1 item
  73. CK2 3item
  74. HIPK2 1 item
  75. HIPK3 1 item
  76. P2X Receptors 1 item
  77. c-Fyn 1 item
  78. TAK1 1 item
  79. P110 1 item
  80. Hck 1 item
  81. Insulin Receptors 1 item
  82. IRG-1R 1 item
  83. Cdc2-like kinase (Clk) 1 item
  84. eEF-2 1 item
  85. Cdc7 1 item
  86. ZAP-70 1 item
  87. c-RET 1 item
  88. p70 rsk 1 item
  89. TAM kinase 1 item
  90. AXL 1 item
  91. c-Fms tyrosine kinase 1 item
  92. STK 1 item
  93. MSK 1 item
  94. Lyn kinase 1 item
  95. ITK 1 item
  96. NUAK 1 item
  97. DCLK2 1 item
  98. Lck 1 item
  99. PKD 1 item
  100. tropomyosin receptor kinase 1 item
  101. SK 1 item
  102. ATM 1 item
  103. PIKfyve 1 item
  104. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 208item
  2. Cell Experiments 128item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 42item
  9. Cancer 153item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 19item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 19item
  17. Glioblastoma 16item
  18. Glioma 6item
  19. Hepatocellular Carcinoma 4item
  20. HIV Infections 1 item
  21. Immunological Diseases 1 item
  22. Inflammatory Bowel Disease 1 item
  23. Inflammatory Diseases 4item
  24. Leukemia 7item
  25. Liver Cancer 3item
  26. Lung Cancer 15item
  27. Lung Carcinoma 3item
  28. Lymphoma 9item
  29. Mantle Cell Lymphoma 1 item
  30. Melanoma 11item
  31. Multiple Myeloma 6item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Non-small Cell Lung Cancer 5item
  36. Non-small Cell Lung Carcinoma 1 item
  37. Ovarian Cancer 14item
  38. Pancreatic Cancer 22item
  39. Prostate Cancer 17item
  40. Psoriasis 1 item
  41. Pulmonary Arterial Hypertension 1 item
  42. Renal Cancer 3item
  43. Renal Cell Carcinoma 5item
  44. Rheumatoid Arthritis 5item
  45. Thyroid Cancer 5item
  46. Type 2 Diabetes 2item